214 related articles for article (PubMed ID: 29088981)
1. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
Grebely J; Applegate TL; Cunningham P; Feld JJ
Expert Rev Mol Diagn; 2017 Dec; 17(12):1109-1115. PubMed ID: 29088981
[TBL] [Abstract][Full Text] [Related]
2. We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?
Grebely J; Matthews S; Causer LM; Feld JJ; Cunningham P; Dore GJ; Applegate TL
Expert Rev Mol Diagn; 2024 Mar; 24(3):177-191. PubMed ID: 38173401
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
[TBL] [Abstract][Full Text] [Related]
4. Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis.
Grebely J; Catlett B; Jayasinghe I; Valerio H; Hajarizadeh B; Verich A; Cunningham P; Martinello M; Tillakeratne S; Silk D; Dore GJ; Applegate TL
J Infect Dis; 2020 Jun; 221(12):2043-2049. PubMed ID: 31993636
[TBL] [Abstract][Full Text] [Related]
5. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
Blackburn NA; Patel RC; Zibbell JE
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
[TBL] [Abstract][Full Text] [Related]
6. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
[TBL] [Abstract][Full Text] [Related]
7. Can hepatitis C virus infection be eradicated in people who inject drugs?
Grebely J; Dore GJ
Antiviral Res; 2014 Apr; 104():62-72. PubMed ID: 24468275
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Diagnosis and the Holy Grail.
Applegate TL; Fajardo E; Sacks JA
Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
[TBL] [Abstract][Full Text] [Related]
9. Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals.
Ward JW
Antivir Ther; 2012; 17(7 Pt B):1397-401. PubMed ID: 23321543
[TBL] [Abstract][Full Text] [Related]
10. What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?
Feld JJ
J Infect Dis; 2024 May; 229(Supplement_3):S316-S321. PubMed ID: 37831406
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of viral hepatitis.
Easterbrook PJ; Roberts T; Sands A; Peeling R
Curr Opin HIV AIDS; 2017 May; 12(3):302-314. PubMed ID: 28306597
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnostics for hepatitis C virus infection.
Kamili S; Drobeniuc J; Araujo AC; Hayden TM
Clin Infect Dis; 2012 Jul; 55 Suppl 1():S43-8. PubMed ID: 22715213
[TBL] [Abstract][Full Text] [Related]
13. Profile of Roche's cobas® HCV tests.
Kessler HH; Stelzl E
Expert Rev Mol Diagn; 2017 Apr; 17(4):311-319. PubMed ID: 28277143
[TBL] [Abstract][Full Text] [Related]
14. What Hepatitis C Virus (HCV) Diagnostic Tools Are Needed to Advance Diagnosis of Current HCV Infection in Outreach Settings and in a Nonclinical Setting?
Page K; Feinberg J
J Infect Dis; 2024 May; 229(Supplement_3):S328-S333. PubMed ID: 37739782
[TBL] [Abstract][Full Text] [Related]
15. Changing strategies for hepatitis C testing.
Teo CG
Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
[TBL] [Abstract][Full Text] [Related]
16. Fast DNA and protein microarray tests for the diagnosis of hepatitis C virus infection on a single platform.
Ember SW; Schulze H; Ross AJ; Luby J; Khondoker M; Giraud G; Terry JG; Ciani I; Tlili C; Crain J; Walton AJ; Mount AR; Ghazal P; Bachmann TT; Campbell CJ
Anal Bioanal Chem; 2011 Nov; 401(8):2549-59. PubMed ID: 21881881
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care testing for HCV infection: recent advances and implications for alternative screening.
Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A
New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283
[TBL] [Abstract][Full Text] [Related]
18. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection.
Gupta E; Agarwala P; Kumar G; Maiwall R; Sarin SK
J Clin Virol; 2017 Mar; 88():46-51. PubMed ID: 28160728
[TBL] [Abstract][Full Text] [Related]
19. The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination.
Kapadia SN; Jordan AE; Eckhardt BJ; Perlman DC
Clin Infect Dis; 2024 May; 78(5):1235-1239. PubMed ID: 37633653
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of true point of care molecular assay using fingerstick capillary whole blood for diagnosis of hepatitis C infection.
Agarwal R; Gupta E; Kumar G; Singh KK; Sharma MK
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33704042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
